Who are the key players in North America Biochips Market industry?

The top 5 players in the North America Biochips Market are Thermo Fisher Scientific, Illumina Inc., Bio-Rad Laboratories, Agilent Technologies, and PerkinElmer. These leading companies drive innovation through advanced biochip solutions for genomics, proteomics, diagnostics, and personalized medicine, supported by robust R&D and market presence.

What is the North America Biochips Market growth?

The North America Biochips Market has experienced significant growth, propelled by increasing adoption of biochip technology in drug discovery and diagnostics. For instance, Illumina reported double-digit growth in its sequencing and array portfolio in 2023, highlighting the rising demand for biochip-based applications across healthcare and research.

Which segment accounted for the largest North America Biochips Market share?

The diagnostics segment held the largest share of the North America Biochips Market. Biochips are widely used for cancer and infectious disease diagnostics due to their high-throughput, accuracy, and cost-effectiveness. Their integration into clinical labs enables rapid, multiplexed testing and supports the expansion of personalized medicine.

What are the factors driving the North America Biochips Market?

Key market drivers include rapid advancements in genomics, personalized medicine, and increasing investments in biotechnology. For example, Thermo Fisher Scientific’s continuous launch of innovative microarray platforms has enabled more efficient diagnostic and research applications, fostering market growth across North America.

Which type accounted for the largest North America Biochips Market share?

DNA chips held the largest market share among biochip types. Their widespread use in gene sequencing, genetic analysis, and disease diagnostics supports high demand. DNA microarrays facilitate large-scale genomic studies, driving research and clinical applications across academic, biotech, and pharmaceutical sectors.

Home Healthcare

North America Biochips Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

Name: North America Biochips Market
Brand: Bussiness Insights

North America Biochips Market Market: by Type (DNA Chips, Lab-on-a-Chip, Protein Chips, Microfluidic Biochips), Application (Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture, Others), Distribution Channels (Direct Tenders, Retail Sales, Online Distribution, Distributors & Wholesalers, Pharmacies, Others), Technology (Microarray, Microfluidics, Nanotechnology, Photolithography, Electrochemical Detection, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025

Last Updated: 31-07-2025 | Format: PDF | Report ID:20318 | Author: Manisha C

RD TOC Segmentation Research Methodology Request For Free Sample

North America Biochips Market Size, Share, Trends & Forecast 2025-2035

The North America biochips market is experiencing robust growth, driven by advances in genomics, proteomics, and personalized medicine. Biochips, also referred to as microarrays or lab-on-a-chip devices, enable simultaneous analysis of thousands of biological samples, revolutionizing diagnostics and drug discovery. They leverage technologies such as microfluidics, nanotechnology, and photolithography to enhance efficiency, automation, and data generation. Applications span drug discovery, disease diagnostics, genomics, proteomics, and agriculture, supported by increasing funding for life sciences, a growing prevalence of chronic diseases, and surging adoption by major pharmaceutical and biotech companies. The market is further propelled by novel distribution strategies, a diverse competitive landscape, and ongoing technological innovations expected to keep North America as a global leader throughout the forecast period.

Latest Market Dynamics

Key Drivers

Rapid adoption of personalized medicine and precision diagnostics, highlighted by Illumina

DNA chips constitute the largest segment in the North America biochips market in 2025, reflecting their widespread application in genomics and disease diagnostics. Lab-on-a-chip technologies also capture significant share, benefiting from innovations that miniaturize laboratory functions onto chip devices. Protein chips continue to see robust demand for proteomics and biomarker discovery, while microfluidic biochips are rapidly gaining ground due to their cost-effectiveness and versatility. As the demand for faster and more accurate diagnostic tools rises, these segments are expected to further drive market growth.

In 2025, disease diagnostics dominate application usage for biochips in North America, reflecting increased healthcare system adoption attracted by accuracy and speed. Drug discovery and development represents the next largest application area, as pharmaceutical companies deploy biochips to accelerate R&D timelines. Genomics and proteomics continue to attract investment for research and clinical applications. Collectively, these segments underscore the pivotal role of biochips in modern medical and research settings, with agriculture and other emerging applications also gaining share.

The North America biochips market revenue demonstrates a strong upward trajectory from 2020 through 2035. In 2025, the market is expected to register USD 3,950 million, with steady double-digit CAGR anticipated over the forecast period. By 2030, revenues are projected to surpass USD 7,800 million, fueled by robust adoption in clinical diagnostics, pharmaceuticals, and academic research. The market's long-term growth underscores the increasing importance of biochips as essential components of the molecular diagnostics and precision medicine ecosystem.

Year-over-year (YOY) growth in the North America biochips market remains robust from 2020 through 2035. Following a surge in demand post-2020, growth rates stabilize near 15% during the mid-to-late 2020s, propelled by advancements in personalized medicine and large-scale genomics initiatives. Although growth moderates slightly entering the 2030s, the market maintains healthy YOY increases, reflecting sustainable expansion and ongoing innovation. The trajectory positions North America as a biochip technology leader globally.

The United States overwhelming dominates the North America biochips market in 2025, commanding over three-quarters of total regional revenue thanks to its vibrant biotech sector, substantial R&D investments, and advanced healthcare infrastructure. Canada follows, benefiting from robust government support and research collaborations, while Mexico's market share is growing with increasing adoption of molecular diagnostics and agricultural biotechnology applications.

Thermo Fisher Scientific leads the North America biochips market in 2025, owing to its expansive product portfolio, advanced technology, and widespread industry partnerships. Illumina, Agilent Technologies, and Bio-Rad Laboratories hold significant market shares as well, each leveraging innovation and strategic acquisitions to enhance their competitive positions. Other key players such as Roche Diagnostics, PerkinElmer, and Fluidigm Corporation continue to shape the market with breakthroughs in diagnostics and research applications.

Pharmaceutical and biotechnology companies remain the largest buyers of biochips in North America in 2025, reflecting their critical role in innovation, drug discovery, and diagnostics. Academic research institutes also constitute a significant proportion of the market, leveraging biochips for genomics and proteomics research. Hospitals and reference laboratories account for growing shares due to the expanding clinical application of biochips in diagnostics, alongside smaller shares from agricultural and veterinary buyers.

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	3950
Regions	United States, Canada, Mexico
Segments	DNA Chips, Lab-on-a-Chip, Protein Chips, Microfluidic Biochips, Tissue & Cell Arrays, Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture, Direct Tenders, Retail Sales, Online Distribution, Distributors & Wholesalers, Pharmacies, Small, Medium, Large
Players	Thermo Fisher Scientific, Agilent Technologies, PerkinElmer, Bio-Rad Laboratories, Illumina, Fluidigm Corporation, Roche Diagnostics, Abbott Laboratories, GE Healthcare, Cepheid, Affymetrix, Life Technologies, Micronit Microtechnologies, Siemens Healthineers, CustomArray

In June 2024, Thermo Fisher Scientific launched its next-generation lab-on-a-chip platform integrating AI-driven data analytics for rapid molecular diagnostics.
Illumina expanded its partnership with North American hospitals in July 2024 to deploy custom DNA chip solutions for precision oncology.
Agilent Technologies announced a strategic alliance in August 2024 with cloud analytics providers to enhance biochip data management and workflow automation.
Bio-Rad Laboratories introduced a new series of portable microfluidic biochips for pandemic preparedness applications in September 2024.
PerkinElmer secured a major contract in October 2024 for supplying agrigenomics biochips across Canadian crop testing centers.

About the Author

Manisha C

Lead Industry Analyst

Manisha C is a Lead Industry Analyst specializing in market research, industry analysis, and business consulting across Healthcare. Manisha C brings a commercially grounded perspective to sectors shaped by changing demand, innovation, and competitive dynamics, helping turn complex market trends into clear strategic insights for business decision-makers. With 10+ years of experience across research, analytics, and strategic advisory roles, Manisha C has helped organizations translate data into actionable growth strategies.

HealthcareMarket ResearchIndustry AnalysisStrategic Consulting

Key Questions Answered

»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?

Download Sample

Why Choose Bussiness Insights?

»Strong Industry Focus
»Extensive Product Offerings
»Customer Research Services
»Robust Research Methodology
»Comprehensive Reports
»Latest Technological Developments
»Value Chain Analysis
»Potential Market Opportunities
»Growth Dynamics
»Quality Assurance
»Post-sales Support
»Regular Report Updates

Speak to Analyst

North America Biochips Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

North America Biochips Market Size, Share, Trends & Forecast 2025-2035

Latest Market Dynamics

Key Drivers

Key Trends

Key Opportunities

Key Challenges

Key Restraints

North America Biochips Market Share by Type, 2025

North America Biochips Market Share by Application, 2025

North America Biochips Market Revenue (USD Million), 2020-2035

North America Biochips Market YOY Growth (%), 2020-2035

North America Biochips Market Share by Region, 2025

North America Biochips Market Players Share, 2025

North America Biochips Market Buyers Share, 2025

Study Coverage

Key Recent Developments

Frequently Asked Questions

About the Author

Related Reports